您的位置: 首页 > 农业专利 > 详情页

Soli in polimorfi 8-fluoro-2-(4-((metilamino)metil)fenil)-1,3,4,5-tetrahidro-6H-azepino (5,4,3-cd)indol-6-ona
专利权人:
Pfizer Inc.
发明人:
BASFORD Patricia Ann,CAMPETA Anthony Michael,GILLMORE Adam,JONES Matthew Cameron,KOUGOULOS Eleftherios,LUTHRA Suman,WALTON Robert,KOUGOULOS Elefth
申请号:
SI201131051
公开号:
SI2534153T1
申请日:
2011.02.10
申请国别(地区):
SI
年份:
2017
代理人:
摘要:
The present invention relates to novel polymorphic forms of 8-fluoro-2-{4-[(methylamino)methyl]phenyf}-1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd]indol-6-one;(I), and to processes for their preparation. Such polymorphic forms may be a component of a pharmaceutical composition and may be used to treat a mammalian disease condition mediated by poly(ADP-ribose) polymerase activity including the disease condition such as cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充